Orlistat
REVIVE
Empros Pharma AB · Phase 2 · Terminated · Enrollment 128
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Metformin | Obesity or overweight | n/r | n/r | n/r | n/r |
| Metformin + Orlistat | Obesity or overweight | n/r | n/r | n/r | n/r |
| Metformin + Topiramate | Obesity or overweight | n/r | n/r | n/r | n/r |
| Topiramate | Obesity or overweight | n/r | n/r | n/r | n/r |
| Metformin + Topiramate + Orlistat | Obesity or overweight | n/r | n/r | n/r | n/r |
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |